白细胞治疗论文 参麦注射液疗效观察论文.docVIP

白细胞治疗论文参麦注射液疗效观察论文 黄芪联合参麦注射液在白细胞减少症中的疗效观察 　　【摘要】 目的 探讨黄芪联合参麦注射液在白细胞减少症中的疗效。方法 将245例白细胞减少症患者随机分为治疗组125例，对照组120例，两组在年龄、性别、疾病程度上比较差异无统计学意义，具有可比性。对照组采用口服鲨肝醇20 mg，3次/d；利血生20 mg，3次/d；维生素B420 mg, 3次/d，饭后服药。治疗组：采用黄芪注射液20 ml,参麦注射液60 ml加入5％葡萄糖注射液250 ml中静脉滴注，1次/d，连用20 d。结果 治疗组总有效率98.4%，对照组总有效率80.83%，两组总有效率比较P0.05差异有统计学意义。结论 采取黄芪联合参麦注射液治疗白细胞减少症临床疗效确切，无明显的毒副作用，安全可靠，是治疗白细胞减少症首选药物。　　【关键词】黄芪联合参麦注射液;白细胞减少症;疗效观察　　　　Astragalus injection in the United Shenmai leukopenia efficacy in　　CHEN Shu-xia.　　First People’s Hospital of Henan Province 476100 Shangqiu　　【Abstract】 Objective To investigate the joint Shenmai Astragalus injection in leukopenia in patients. Methods 245 cases of leukopenia were divided into treatment of 125 cases, 120 cases of the control group, the two groups in age, sex, disease, no difference in the degree of clinical comparability. Control group with oral administration of shark liver alcohol 20 mg, 1, 3 times; leucogen 20 mg, 1 3 times a day; vitamin B420 mg, 1 3 times a day, after meals medication. Treatment group:Astragalus 20 ml, Shen Mai injection 60 ml 5% glucose injection 250 ml in intravenous infusion, day 1, once every 20 days. Results The total effective rate of 98.4% in the control group, the total efficiency of 80.83%, total effective rate between the two groups pP0.05 significant difference. Conclusion The observation of two groups of patients, the treatment group, the total efficiency of 98.4% in the control group, the total efficiency of 80.83%, total effective rate between the two groups pP0.05 significant difference. Take astragalus injection combined Shenmai leukopenia clinical efficacy, no significant side effects, safety and reliability, is the drug of choice for treatment of leukopenia　　【Key words】Astragalus United Shenmai injection; leukopenia; efficacy　　　　白细胞减少症是指多种原因引起的外周血白细胞持续低于正常值的综合征，临床较为常见［1］。在血液系统病变中进行化疗治疗时由于对骨髓的不同程度的毒性、抑制作用，白细胞减少症常常存在，出现感染发热现象，常常导致化疗中断、化疗时间推迟及化疗药物减量，影响治疗效果。为了能够缩　　短粒细胞缺乏症的持续时间，加速白细胞数的恢复，从而减少　　合并感染和发热的危险，我们采用黄芪联合